Galapagos Genomics NV, The Netherlands Cancer Institute deal

The parties will identify and validate targets for cancer therapy, including cell cycle regulatory genes, using Galapagos’s PhenoSelect arrayed recombinant adenoviral human gene libraries with cell-ba...